ORN Fall 2026 - Pharmacokinetics and breast milk transfer of naltrexone and extended-release buprenorphine in pregnant and lactating individuals with substance use disorders.

Description:

In this course, learners will receive an overview of what is known about the use of naltrexone for the treatment of opioid and/or alcohol use disorder in pregnant and postpartum patients, with a focus on pharmacokinetics and breast milk transfer. In addition, learners will receive an overview of the use of extended-release forms of buprenorphine for pregnant and postpartum individuals, as well as breast milk transfer of extended-release buprenorphine for those with opioid use disorder.

Learning objectives:

At the conclusion of this seminar, attendees should be able to:

Understand perinatal outcomes after use of naltrexone in pregnancy for the treatment of opioid and/or alcohol use disorder.
Understand the breast milk and neonatal transfer of naltrexone and extended-release buprenorphine.
Understand maternal outcomes after use of extended-release buprenorphine in pregnant and postpartum women with opioid use disorder.

CME

Continuing Medical Education (CME) Credits Available

Participants in this program may earn the following CME credits:

✔ 1 AOA Category 1-A Credit
✔ 1 AMA PRA Category 1 Credit™
✔ 1 AAPA Category 1 CME Credit
✔ 1 Nurses CNE Credit

Earn valuable continuing education credits while enhancing your professional knowledge!

Instructions and Claiming CME

Need help claiming your CME certificate? Download the instructions here.
Note: Video content must be watched in its entirety and surveys must be complete to claim CME certificates. The survey opens in a new browser tab. You must complete the survey and return to the original browser tab, answer the attestation question, then claim your CME.

What is ORN

Help is here! The Opioid Response Network (ORN) is your resource for no-cost education, training and consultation to enhance efforts addressing opioid and stimulant use disorders.
ORN has consultants in every state and territory to deploy across prevention, treatment, recovery and overdose prevention.
Share your needs via the “Submit a Request” form at www.OpioidResponseNetwork.org. Within one business day, your regional point person will be in touch to learn more.

Speaker:

Elisha Wachman MD

Dr. Elisha Wachman is a Professor of Pediatrics at the Boston University Chobanian & Avedisian School of Medicine, an attending neonatologist at Boston Medical Center (BMC), and Vice Chair for Research in the Department of Pediatrics at BMC. Dr. Wachman also serves as Co-Lead of the Massachusetts Perinatal Neonatal Quality Improvement Network Perinatal Opioid Project (PNQIN POP). She is an internationally recognized leader in Neonatal Opioid Withdrawal Syndrome (NOWS) and substance use disorders in pregnancy, conducting innovative clinical and translational research and leading quality improvement interventions in this area. Her research is funded by the NIH, CDC, Massachusetts Department of Public Health, Gerber Foundation, and March of Dimes Foundation and has included the investigation of optimal pharmacologic treatment regimens for infants with NOWS; novel approaches to the pharmacologic treatment of pregnant persons with opioid use disorder; clinical, genetic, and epigenetic markers of NOWS outcomes; and the examination of long-term childhood outcomes after prenatal opioid exposure.

DISCLAIMER

ACCREDITATION:
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary

Availability:

Registration Required

Access expires on Oct 01, 2029

Location:

Online Meeting

Date / Time:

Sep 02, 2026 5:00 PM - 6:00 PM ET

Cost:

FREE

Credit Offered:

1 AAPA Category 1 CME Credit

1 AMA PRA Cat 1 Credit

1 Nurses CNE Credit

1 AOA Category 1A Credit

Create Account